Literature DB >> 9139687

Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells.

S Iwase1, Y Furukawa, J Kikuchi, M Nagai, Y Terui, M Nakamura, H Yamada.   

Abstract

E2F is a heterodimeric transcription factor that controls transcription of several growth-regulatory genes including cdc2. To investigate the mechanism of interferon-alpha (IFN-alpha)-mediated growth suppression of hematopoietic cells, we examined the effect of IFN-alpha on the expression and function of E2F using IFN-sensitive Daudi cells. Down-regulation of E2F-1, a subunit of E2F, was observed after 8 h of culture with IFN-alpha; expression of E2F-4, another subunit of E2F, and DP-1, a heterodimeric partner of E2F, was unaffected. Gel shift assays revealed that the DNA binding activity of free E2F, which is composed of E2F-1 and E2F-4, was inhibited by IFN-alpha. In contrast, IFN-alpha did not affect the DNA binding ability of E2F-1 and E2F-4 in a complex with retinoblastoma (RB) susceptibility gene family proteins including pRB, p107, and p130. IFN-alpha could induce dephosphorylation of pRB, thereby turning active E2F-pRB complexes into transcriptional repressors. Transient chloramphenicol acetyltransferase assays revealed that the activity of the E2F-dependent cdc2 promoter was suppressed by IFN-alpha. These results suggest that the antiproliferative action of IFN-alpha is mediated through the modulation of E2F activity in two different ways: down-regulation of transcriptionally active free E2F and conversion of E2F-pRB complexes into transcriptional repressors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9139687     DOI: 10.1074/jbc.272.19.12406

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by alpha/beta interferon in T lymphocytes.

Authors:  Ramon Gimeno; Chien-Kuo Lee; Christian Schindler; David E Levy
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

2.  DNA damage signaling and p53-dependent senescence after prolonged beta-interferon stimulation.

Authors:  Olga Moiseeva; Frédérick A Mallette; Utpal K Mukhopadhyay; Adrian Moores; Gerardo Ferbeyre
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

3.  Genome-wide analysis of target genes regulated by HoxB4 in hematopoietic stem and progenitor cells developing from embryonic stem cells.

Authors:  Motohiko Oshima; Mitsuhiro Endoh; Takaho A Endo; Tetsuro Toyoda; Yaeko Nakajima-Takagi; Fumihiro Sugiyama; Haruhiko Koseki; Michael Kyba; Atsushi Iwama; Mitsujiro Osawa
Journal:  Blood       Date:  2011-02-22       Impact factor: 22.113

4.  Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.

Authors:  Y Shechter; L Preciado-Patt; G Schreiber; M Fridkin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

5.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene.

Authors:  M Chatterjee-Kishore; K L Wright; J P Ting; G R Stark
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

6.  Disruption of mutually negative regulatory feedback loop between interferon-inducible p202 protein and the E2F family of transcription factors in lupus-prone mice.

Authors:  Ravichandran Panchanathan; Hong Xin; Divaker Choubey
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

7.  Viral hepatitis and hepatocellular carcinoma.

Authors:  Peter P Michielsen; Sven M Francque; Jurgen L van Dongen
Journal:  World J Surg Oncol       Date:  2005-05-20       Impact factor: 2.754

8.  Gene activity in primary T cells infected with HIV89.6: intron retention and induction of genomic repeats.

Authors:  Scott Sherrill-Mix; Karen E Ocwieja; Frederic D Bushman
Journal:  Retrovirology       Date:  2015-09-17       Impact factor: 4.602

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.